Abstract
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Highlights
Summary of results We observed a statistically significant decrease in serum phosphate levels in the three different cardiovascular risk (CVR) groups
Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients
This study was performed to determine whether serum phosphate levels are associated with increased risk for cardiovascular events
Summary
From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 7-11 November 2010. From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. Purpose of the study Hypophosphatemia may contribute directly to the development of obesity, hypertension and dyslipidemia. Hyperglycemia, insulin resistance, hyperlipidemia and hypertension, which are components of metabolic syndrome, are recognized as strong risk factors for cardiovascular disease [1]. This study was performed to determine whether serum phosphate levels are associated with increased risk for cardiovascular events
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
